Increased coexpression of PD-L1 and TIM3/TIGIT is associated with poor overall survival of patients with esophageal squamous cell carcinoma

BACKGROUND: Immune checkpoint (IC) blockades (ICBs) significantly improve patients’ clinical outcomes with solid tumors. Because the objective response rate of single-agent ICB is limited, it is meaningful to explore the combination of ICs for immunotherapy. METHODS: RNA sequencing data of 95 newly...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Peipei, Chen, Yueyun, Long, Qingqin, Li, Qing, Tian, Jiangfang, Liu, Ting, Wu, Yong, Ding, Zhenyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504357/
https://www.ncbi.nlm.nih.gov/pubmed/34625514
http://dx.doi.org/10.1136/jitc-2021-002836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504357/
https://www.ncbi.nlm.nih.gov/pubmed/34625514
http://dx.doi.org/10.1136/jitc-2021-002836

Ejemplares similares